newsfilter
← Latest News
GlobeNewswire·

Excellere Partners and GHO Capital complete sale of Biocare Medical to Agilent Technologies

A
  • Excellere Partners & GHO Capital Partners completed the sale of Biocare Medical to Agilent Technologies on 25 June 2026.
  • Biocare is a global leader in immunohistochemistry, in situ hybridization, & fluorescence in situ hybridization solutions.
  • Under the ownership of Excellere & GHO, Biocare achieved double-digit revenue & profitability growth while expanding into molecular diagnostics.
  • The acquisition combines two businesses with aligned strategies to unlock market access, enhance customer support, & accelerate innovation.
  • Excellere & GHO highlighted Biocare's transatlantic reach & leading position in IHC solutions as key drivers for the transaction's success.
  • Agilent's acquisition aims to deliver greater value to customers & patients through Biocare's integration into Agilent's global resources.
  • Biocare provides automated instrumentation, high-quality reagents, & multiplexing capabilities to advance cancer diagnostics & research.